Healthy high growth potential

Results

1469

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1469 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł224.50-0.7%-16.8%zł22.4bzł235.1343.429.7%0.4%Media
FWRY
ج.م18.40-3.2%50.8%ج.م62.7bج.م22.4523.627.3%n/aDiversified Financials
AXSM
US$240.661.2%131.6%US$12.6bUS$276.4717.557.4%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.07-12.4%-48.0%SEK 292.9mSEK 1.602.682.7%n/aTech
MDGL
US$514.390.9%71.4%US$12.4bUS$678.7110.559.2%n/aPharmaceuticals & Biotech
AGP
€7.02-1.5%-8.4%€128.0m€8.5725.837.8%n/aCapital Goods
2368
NT$1,230.00-0.8%324.1%NT$616.6bNT$1,485.0054.838.2%0.8%Tech
2455
NT$349.00-10.2%168.5%NT$66.3bNT$382.40110.245.2%0.8%Semiconductors
456A
JP¥1,402.00-8.4%n/aJP¥124.3bn/a39.723.4%n/aRetail
4417
JP¥4,055.0022.9%35.6%JP¥57.3bJP¥4,500.0041.024.1%0.8%Software
MOD
US$244.49-11.6%139.2%US$14.1bUS$340.86106.349.3%n/aCapital Goods
RHM
€1,050.6010.7%-39.3%€48.9b€1,765.6046.630.7%1.1%Capital Goods
CRDO
US$259.09-3.7%189.9%US$50.7bUS$269.81102.327.5%n/aSemiconductors
CORT
US$88.488.5%24.0%US$9.3bUS$88.00203.548.9%n/aPharmaceuticals & Biotech
NVDA
US$197.58-0.7%25.6%US$4.8tUS$301.6230.022.2%0.5%Semiconductors
LITE
US$801.16-4.9%778.1%US$66.8bUS$1,111.29142.079.1%n/aTech
688072
CN¥832.001.1%456.3%CN¥234.1bCN¥511.08142.435.2%0.04%Semiconductors
7769
NT$7,030.001.6%428.6%NT$1.3tNT$9,322.7187.743.7%0.9%Semiconductors
9218
JP¥733.003.8%12.8%JP¥7.6bn/a32.428.9%1.4%Healthcare
688270
CN¥81.3719.1%140.8%CN¥24.8bCN¥185.71162.285.5%0%Semiconductors
PNI
AU$17.855.4%-13.0%AU$4.1bAU$22.1333.321.1%3.1%Diversified Financials
AV1
AU$0.077-3.8%-33.0%AU$72.3mAU$0.177.5108.4%n/aSoftware
6223
NT$7,240.004.9%609.8%NT$656.0bNT$7,502.73192.855.5%0.3%Semiconductors
SKS
AU$8.74-4.9%356.4%AU$1.0bAU$8.9058.942.4%0.7%Capital Goods
Page 1 of 41